| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership | 
|---|---|---|---|---|---|---|---|
| OptimizeRx Corp | Chief Legal & Admin Officer | Common Stock | 90.6K | $1.7M | $18.75 | Oct 3, 2025 | Direct | 
| OptimizeRx Corp | Chief Legal & Admin Officer | Restricted Stock Units | 0 | $0 | $10.70 | Oct 3, 2025 | Direct | 
| OptimizeRx Corp | Chief Legal & Admin Officer | Stock Option | 35.2K | Aug 21, 2025 | Direct | 
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role | 
|---|---|---|---|---|---|---|---|
| OPRX | OptimizeRx Corp | Oct 3, 2025 | 3 | -$36.6K | 4 | Oct 7, 2025 | Chief Legal & Admin Officer | 
| OPRX | OptimizeRx Corp | Aug 21, 2025 | 2 | $0 | 4 | Aug 25, 2025 | Chief Legal & Admin Officer | 
| OPRX | OptimizeRx Corp | Mar 1, 2025 | 3 | -$1.39K | 4 | Mar 4, 2025 | Chief Legal Officer & CHRO | 
| OPRX | OptimizeRx Corp | Feb 15, 2025 | 1 | -$9.82K | 4 | Feb 20, 2025 | Chief Legal Officer & CHRO | 
| OPRX | OptimizeRx Corp | Feb 11, 2025 | 3 | -$7.76K | 4 | Feb 13, 2025 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Dec 23, 2024 | 2 | $0 | 4 | Dec 27, 2024 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Dec 19, 2024 | 3 | -$5.48K | 4 | Dec 20, 2024 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Nov 8, 2024 | 3 | -$3.29K | 4 | Nov 12, 2024 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Oct 3, 2024 | 3 | -$15.3K | 4 | Oct 7, 2024 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Mar 1, 2024 | 3 | -$4.27K | 4 | Mar 6, 2024 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Feb 15, 2024 | 1 | $0 | 4 | Apr 24, 2024 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Feb 11, 2024 | 3 | -$21.3K | 4 | Feb 13, 2024 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Jan 9, 2024 | 1 | -$60.8K | 4 | Jan 11, 2024 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Dec 19, 2023 | 2 | $0 | 4 | Feb 21, 2024 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Nov 8, 2023 | 3 | -$4.83K | 4 | Nov 13, 2023 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Oct 3, 2023 | 3 | -$13.8K | 4 | Oct 6, 2023 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Mar 1, 2023 | 3 | -$4.85K | 4 | Mar 3, 2023 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Feb 11, 2023 | 3 | -$24.7K | 4 | Feb 14, 2023 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Nov 8, 2022 | 3 | -$10.3K | 4 | Nov 10, 2022 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Oct 3, 2022 | 2 | $0 | 4 | Oct 5, 2022 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Aug 26, 2022 | 1 | $15.8K | 4 | Aug 30, 2022 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Mar 1, 2022 | 2 | $0 | 4 | Mar 3, 2022 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Feb 11, 2022 | 2 | $0 | 4 | Feb 15, 2022 | General Counsel and CCO | 
| OPRX | OptimizeRx Corp | Nov 8, 2021 | 2 | $0 | 4 | Nov 10, 2021 | General Counsel and CCO |